首页> 外文学位 >Synthesis and evaluation of a [fluorine-18]-labelled antisense oligonucleotide as an imaging probe to measure cellular response to radiation therapy.
【24h】

Synthesis and evaluation of a [fluorine-18]-labelled antisense oligonucleotide as an imaging probe to measure cellular response to radiation therapy.

机译:合成和评估[氟-18]标记的反义寡核苷酸作为成像探针,以测量细胞对放射治疗的反应。

获取原文
获取原文并翻译 | 示例

摘要

Antisense oligodeoxynucleotides (asODNs) show strong binding and high selectivity and can be constructed to recognize specific cellular targets such as gene regulated mRNA. Radiolabelled asODNs have the potential to image gene expression through mRNA targeting and could be a valuable tool in the early assessment of outcome to cancer treatment. We have explored the potential of in vivo imaging of p21 gene expression, using fluorine-18 labelled asODNs ([18F]asODNs) and in vitro techniques, recognizing the relationship between the expression of this gene and resistance of cancer cells to radiation therapy. Radiolabelling of fully phosphorothioated, 20-mer ODNs was performed using the [18F]-labelled prosthetic group, 4-N-[18F]fluorobenzyl-2-bromoacetamide ([18F]FBBA). [18F]FBBA was first synthesized in an automated synthesis unit, resulting in a modest radiochemical yield. Methods to improve the yield were investigated using a metal catalyst-assisted borohydride exchange resin. Alkylation of [18F]FBBA to ODN resulted in radiochemical yields of 40%. Cellular uptake and retention studies were performed in human carcinoma cells expressing p21+/+ (HCT116) and the p21 knock-out cell line, 80S4, using both [18F]-labelled antisense and random sequence ODNs. Nonradioactive FBBA-labelled ODNs were used to evaluate the antisense effectiveness and distribution of the FBBA-modified ODNs. In vitro studies demonstrated that FBBA did not interfere with the antisense effect of ODNs against p21 mRNA; however, the probes required a transfection agent to observe an antisense effect. Cell fractionation studies with [18F]ODNs revealed increasing accumulation of liposome-transfected [18F]asODN in the cytoplasm of HCT116 cells over time. A biocompatible spermine-grafted block copolymer (SP) was subsequently evaluated as a potential vector to improve the delivery of [ 18F]asODN into cells. SP was shown to direct [F]-labelled ODNs to the cytoplasm, whereas naked [F]ODNs remained sequestered in vesicles, and liposome-transfected [F]ODNs localized mostly in the nucleus. Selective uptake and retention of [18F]asODN was observed in p21+/+ cells only when the probe was transfected with SP. Based on these studies, it can be concluded that [18F]asODNs have the potential to image gene expression, however the focus may need to be directed to find an appropriate vector which can rapidly deliver [18F]-labelled asODNs to the target tissue in vivo.
机译:反义寡聚脱氧核苷酸(asODN)显示出强大的结合力和高选择性,可以构建为识别特定的细胞靶标,例如基因调控的mRNA。放射性标记的asODN具有通过mRNA靶向成像基因表达的潜力,并且可能是早期评估癌症治疗结果的有价值的工具。我们利用氟18标记的asODNs([18F] asODNs)和体外技术探索了p21基因表达在体内成像的潜力,认识到该基因的表达与癌细胞对放射治疗的抵抗力之间的关系。使用[18F]标记的修复基团4-N- [18F]氟苄基-2-溴乙酰胺([18F] FBBA)对完全硫代磷酸酯化的20-mer ODN进行放射性标记。 [18F] FBBA首先在自动合成装置中合成,产生适度的放射化学产率。使用金属催化剂辅助的硼氢化物交换树脂研究了提高产率的方法。 [18F] FBBA烷基化为ODN导致放射化学产率为40%。使用[18F]标记的反义和随机序列ODN在表达p21 + / +(HCT116)的人癌细胞和p21敲除细胞系80S4中进行细胞摄取和保留研究。使用非放射性FBBA标记的ODN评估FBBA修饰的ODN的反义效力和分布。体外研究表明,FBBA不会干扰ODN对p21 mRNA的反义作用。但是,探针需要转染剂才能观察到反义作用。 [18F] ODNs的细胞分离研究表明,随着时间的推移,脂质体转染的[18F] asODN在HCT116细胞的细胞质中的积累增加。随后评估了生物相容性的精胺接枝嵌段共聚物(SP)作为潜在的载体,以改善[18F] asODN进入细胞的传递。 SP已显示将[F]标记的ODN引导到细胞质,而裸露的[F] ODN仍然被隔离在囊泡中,脂质体转染的[F] ODN大部分位于细胞核中。仅当用SP转染探针时,才在p21 + / +细胞中观察到[18F] asODN的选择性摄取和保留。基于这些研究,可以得出结论[18F] asODN具有成像基因表达的潜力,但是可能需要着重寻找合适的载体,该载体可以将[18F]标记的asODN迅速递送至靶组织中。体内。

著录项

  • 作者

    Koslowsky, Ingrid.;

  • 作者单位

    University of Alberta (Canada).;

  • 授予单位 University of Alberta (Canada).;
  • 学科 Health Sciences Pharmacy.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 159 p.
  • 总页数 159
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 老年病学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号